Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2010
07/07/2010CN101768215A House lizard glycopeptide, method for preparing same and medicinal application thereof
07/07/2010CN101766810A Medical preparation containing recombinant human granulocytecolony stimulating factor
07/07/2010CN101260397B Application of immobilized proteinase in preparing cream protein peptide
07/06/2010US7750204 Methods for producing antibody
07/06/2010US7750138 consisting of different fragments of the VEGF receptors FLT-1 and KDR and human immunoglobulin Fc; treatment of angiogenesis-related diseases including tumor, diabetic retinopathies, arthritis, anemia and endometrial hyperplasia; vectors; host cell
07/06/2010US7750135 Molecular design of thermostable alcohol dehydrogenase for synthesis for chiral aromatic alcohols
07/06/2010US7750126 Antibodies that bind to a member of the IL-6/G-CSF/MGF family
07/06/2010US7750125 C35 tumor antigen specific monoclonal for use in diagnosis, prevention and treatment of cell proliferative disorders
07/06/2010US7750124 Delta-like 4 receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
07/06/2010US7750123 Immunoglobulin for treatment and prevention of severe acute respiratory syndrome and/or coronavirus related disorders
07/06/2010US7750121 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents
07/06/2010US7749758 Human and mammalian stem cell-derived neuron survival factors
07/06/2010US7749753 modulation of transport proteins in biological cells; genetic engineering; antibodies
07/06/2010US7749745 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine
07/06/2010US7749742 Method for producing tripeptides and/or peptides longer than tripeptides
07/06/2010US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta
07/06/2010US7749733 Expression vector for identifying promoter region of genes; gene expression modulators
07/06/2010US7749732 Method for preparing active nanoarchaeum equitans DNA polymerase and the active DNA polymerase prepared by the method
07/06/2010US7749731 Using acid lysis to release translation products from cells
07/06/2010US7749719 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
07/06/2010US7749718 Method for raising or isolating an antibody to DCRS5
07/06/2010US7749518 Viral protein for use in devloping vaccine for treatment and preventon of infection, vision, arthritic and respiratory system disorders
07/06/2010US7749514 Activatable clostridial toxins
07/06/2010US7749506 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans
07/06/2010US7749504 Anti-TAT188 antibodies
07/06/2010US7749502 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis
07/06/2010US7749500 Antibodies to IL-17 polypeptides and therapeutic uses thereof
07/06/2010US7749499 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics
07/06/2010CA2373491C Method of detecting interacting proteins
07/06/2010CA2363537C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
07/06/2010CA2264509C Novel monoclonal antibody recognizing cell surface antigen cd14
07/06/2010CA2209360C Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
07/06/2010CA2162729C Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s)
07/06/2010CA2123049C Pharmaceutical containing the p40 subunit of interleukin 12
07/01/2010WO2010075194A1 Prokaryotic expression of soluble, active dkk
07/01/2010WO2010074821A1 Acidothermus celluloyticus xylanase
07/01/2010WO2010074266A1 Anti-cd4 antibody
07/01/2010WO2010074218A1 Anti-human midkine antibody
07/01/2010WO2010074192A1 Diagnosis and treatment of cancer using anti-lgr7 antibody
07/01/2010WO2010074081A1 Protein substance having triple helix structure and manufacturing method therefor
07/01/2010WO2010074080A1 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof
07/01/2010WO2010074049A1 Anti-hs6st2 antibody and use thereof
07/01/2010WO2010073694A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody
07/01/2010WO2010073531A1 Muscle-building agent
07/01/2010WO2010054156A3 Vaccines targeting cellular death receptors
07/01/2010US20100169992 Fgfr4 antibodies
07/01/2010US20100168398 Method, computing routine, device for predicting properties of MHC/peptide complexes, and data and peptides produced therefrom.
07/01/2010US20100168396 Novel Branchiostoma Derived Fluorescent Proteins
07/01/2010US20100168392 Expression of full length igg and secretion into the culture medium of prokaryotic cells
07/01/2010US20100168389 Process for producing extract for cell-free protein synthesis and cell extract produced thereby
07/01/2010US20100168380 Process for synthesizing cyclic peptide compound
07/01/2010US20100168214 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
07/01/2010US20100168213 Protein-coding RNA to correct mitochondrial dysfunction
07/01/2010US20100168028 Compositions and methods of using crmp-1 and its fragments for treating cancer
07/01/2010US20100168027 Bpc-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
07/01/2010US20100168021 Urocortin proteins and uses thereof
07/01/2010US20100168020 Stabilized receptor polypeptides and uses thereof
07/01/2010US20100168015 Peptides with capacity for binding with interleukine 10 (il-10)
07/01/2010US20100167957 Methods for producing active scfv antibodies and libraries therefor
07/01/2010US20100167393 Modified human thymic stromal lymphopoietin
07/01/2010US20100167348 Peptide capable of binding to immunoglobulin
07/01/2010US20100167347 used to incorporate a selected amino acid in a specific position in a growing polypeptide chain (during nucleic acid translation) in response to a selector codon that is recognized by the tRNA
07/01/2010US20100167346 Method of producing heterogeneous protein
07/01/2010US20100167345 Halohydrin dehalogenases and related polynucleotides
07/01/2010US20100167344 Novel sialidases
07/01/2010US20100167343 Oviduct specific expression promoter and recombinant expression vector comprising the same
07/01/2010US20100167342 Method of producing biologically active polypeptide having insulinotropic activity
07/01/2010US20100167341 Novel protein expression system
07/01/2010US20100167340 Method to produce a receptor chip using biotinylated protein
07/01/2010US20100167298 PURO-DHFR Quadrifunctional Marker and its use in Protein Production
07/01/2010US20100167292 High fidelity polymerases and uses thereof
07/01/2010US20100166824 Extracellular matrix compositions
07/01/2010US20100166799 Adenoviral vectors and methods and uses related thereto
07/01/2010US20100166792 Antigenic Polypeptides
07/01/2010US20100166786 A mycobacterium tuberculosis fusion protein and uses thereof
07/01/2010US20100166785 lipopeptide or lipoprotein that is not only highly immunogenic itself but also can enhance the immunogenicity of other antigens; vaccine
07/01/2010US20100166772 ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n
07/01/2010US20100166769 High-yield Transgenic Mammalian Expression System for Generating Virus-like Particles
07/01/2010US20100166768 High Affinity Human Antibodies to PCSK9
07/01/2010US20100166767 Engineered anti-il-23r antibodies
07/01/2010US20100166766 Engineered anti-tslp antibody
07/01/2010US20100166763 Method for determining the immunogenicity of an antigen
07/01/2010US20100166761 Compositions and methods for the treatment of immune related diseases
07/01/2010US20100166758 Novel antibody molecules and nucleic acids
07/01/2010US20100166753 Humanized monoclonal antibodies that protect against shiga toxin induced disease
07/01/2010US20100166749 Polypeptide variants with altered effector function
07/01/2010US20100166748 C5 Antigens and Uses Thereof
07/01/2010US20100166733 Mcp-1 splice variants and methods of using same
07/01/2010US20100166732 Small streptococcus pyogenes antigens and their use
07/01/2010US20100166725 Human Cystathionine beta-Synthase Variants and Methods of Production Thereof
07/01/2010US20100166658 Monkey homolog of human oncostatin m
07/01/2010CA2748990A1 Diagnosis and treatment of cancer using anti-lgr7 antibody
07/01/2010CA2748135A1 Heterologous biomass degrading enzyme expression in thermoanaerobacterium saccharolyticum
07/01/2010CA2748015A1 Protein substance having triple helix structure and manufacturing method therefor
07/01/2010CA2748011A1 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof
07/01/2010CA2747827A1 System for production of ethanol and co-products
07/01/2010CA2746929A1 Acidothermus celluloyticus xylanase
06/2010
06/30/2010EP2202315A1 Modified vaccinia ankara virus variant
06/30/2010EP2202308A2 Methods and compositions for polypeptide engineering
06/30/2010EP2202307A1 Method for production of antibody